Table 5.
Performance Measures | PSC | Preparing for Certification | Non‐PSC (Ref) |
---|---|---|---|
1. Received deep vein thrombosis prophylaxis | 2.3 | 1.1* | 5.1 |
2. Discharged on antithrombotic | −0.1 | 0.2 | 0.1 |
3. Patients with atrial fibrillation received anticoagulant | 3.4 | 9.9 | 7.7 |
4 a. IV tPA received (among eligible ischemic strokes) | 1.6 | 3.0 | 1.1 |
b. IV tPA considered | 9.9 | 18.4* | 5.3 |
c. IV tPA received (among all ischemic strokes) | <−0.1* | 0.9* | 0.1 |
5. Received antithrombotics within 48 hours | 2.3 | 4.5 | 4.3 |
6 a. Lipid profile measured during hospitalization | 7.9 | 10.3* | 6.3 |
b. If lipid profile measured, discharged on statin | 1.1* | 3.1* | 2.2 |
7. Screened for dysphasia | 3.9 | 6.6 | 3.7 |
8. Given stroke education | 6.7 | 6.3 | 6.9 |
9. Given smoking cessation counseling | 8.2* | 3.2 | 2.1 |
10. Considered for a rehabilitation plan | 1.9 | 2.5 | 2.0 |
Defect‐free care | 7.7* | 8.1* | 3.7 |
Denominators vary based on exclusion/inclusion criteria. PSC indicates primary stroke center; IV tPA, intravenous tissue plasminogen activator.
Compliance measured in 3‐month intervals, with the first 2 months of data excluded.
F‐test P<0.05.
F‐test P<0.01.